FDA recalls Silintan joint-pain capsules after hidden meloxicam found in product sold online

The FDA has posted a nationwide recall for Silintan capsules, a product marketed online for joint and body aches, after testing found undeclared meloxicam in the capsules. That matters because meloxicam is a nonsteroidal anti-inflammatory drug, or NSAID, and people using Silintan would not know they were taking it.

When a drug ingredient is hidden inside a product sold as a dietary supplement, the risk is not just the ingredient itself. The bigger problem is that people may unknowingly combine it with other medicines, take it despite a medical condition that makes NSAIDs risky, or miss early warning signs because they do not realize they have been exposed.

What changed

The FDA published the recall on January 9, 2026. According to the recall notice, Silintan capsules were sold online nationwide in the United States and the recall applies to all lots within expiry.

This was not a brand-new concern. On September 23, 2025, the FDA had already warned consumers not to buy or use SILINTAN after laboratory testing found hidden meloxicam that was not listed on the label.

In other words, federal regulators had already identified the product as unsafe before the January 2026 recall was posted.

Why hidden meloxicam is a serious safety issue

Meloxicam belongs to the NSAID family, the same broad drug class as ibuprofen and naproxen. These medicines can be useful when a clinician recommends them, but they are not harmless for everyone.

Undeclared exposure is the core danger here. A person might take Silintan thinking it is an herbal or natural supplement, while also taking aspirin, ibuprofen, naproxen, or a prescription blood thinner. That kind of overlap can raise the risk of stomach bleeding and other serious complications.

NSAIDs can also increase the risk of ulcers, bleeding in the stomach or intestines, kidney injury, and certain heart-related problems in some people. FDA has also warned that higher meloxicam exposure may raise the risk of blood clots, heart attack, and stroke.

This does not mean meloxicam is unsafe for every patient when it is properly prescribed and monitored. The problem in this recall is that the drug was present without being disclosed on the label.

Who may face higher risk

Some people could be more likely to have serious problems after using a product with hidden meloxicam, including:

people taking blood thinners
people taking aspirin, ibuprofen, naproxen, or other NSAID medicines
people taking corticosteroids such as prednisone
people with a history of stomach ulcers or gastrointestinal bleeding
people with kidney disease
people with heart disease or certain cardiovascular risk factors
older adults
pregnant people, unless their own clinician has advised otherwise

People who take several pain products at once may be at special risk because they may not realize one of them already contains an NSAID.

Symptoms that should not be ignored

Anyone who used Silintan should watch for warning signs of serious side effects. Seek urgent medical care right away for symptoms such as:

black or bloody stools
vomiting blood or vomit that looks like coffee grounds
severe stomach pain
chest pain
shortness of breath
sudden weakness, trouble speaking, or other possible stroke symptoms
swelling or sudden fluid retention
reduced urination
rash or signs of an allergic reaction

Not everyone who used the product will have complications. But these symptoms deserve prompt attention because NSAID-related bleeding, allergic reactions, kidney injury, and heart or circulation problems can become serious quickly.

What consumers should do now

If you have Silintan capsules, stop using them. Check the packaging to confirm the product name and follow the recall instructions from the company and FDA.

If you took the product and had symptoms, or if you may have combined it with blood thinners, aspirin, ibuprofen, naproxen, steroids, or other medicines that affect bleeding or kidney function, contact a clinician or pharmacist for personal guidance. They can help you think through possible interactions and whether you need follow-up care.

Consumers can also report side effects or product problems through FDA MedWatch.

Why this matters beyond one product

FDA has previously warned that some products marketed for pain or arthritis relief, especially products promoted online as herbal or natural, have contained hidden drug ingredients. That does not mean every supplement is unsafe. It does mean label claims should not automatically be taken at face value, especially when a product promises relief for pain, inflammation, or arthritis.

A practical takeaway for readers is simple: a product sold as a supplement can still contain an undeclared medicine. If you bought or used Silintan, stop using it, watch for serious warning signs, and get medical advice if you may have had an interaction or side effect.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.